跳至主要内容
临床试验/IRCT20200415047092N1
IRCT20200415047092N1已完成3 期

Safety and Effectiveness of azithromycin in Patients with COVID-19 Referred to zeiaeian Hospital : A clinical trial study

Tehran University of Medical Sciences0 个研究点目标入组 110 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Obtaining informed consent from patient or patient’s legal proxy for inclusion in this study.-
  • Patients must be over 18 years of age-
  • A documented positive PCR test for SARS-CoV-2 or one of the following criteria:1.Compelling clinical symptoms associated with a covid-19 infection; including: fever, dry cough and dyspnea2.A typically involvement of lungs observed in HRCT or Spiral CT scanning that can be strongly attributed to a covid-19 pneumonia3.
  • Patients that have developed known complications of a covid-19 infection such as acute respiratory distress syndrome (ARDS) or myocarditis.

排除标准

  • pregnancy or nursing
  • Patients whose covid-10 infection has not been proven and have symptoms that can be attributed to either the common cold or influenza and/or have had a positive PCR test for influenza.
  • known allergy to chloroquine or hydroxylchloroquine
  • retinopathy
  • G6PD deficiency
  • prolonged QT interval
  • severe heart failure
  • Pacemaker implantation
  • cardiac arrhythmia

研究者

相似试验

The effect of azithromycin in treatment of COVID19 | 临床试验